GPT-Rosalind: AI Designed for Drug Discovery and Research

OpenAI has launched GPT-Rosalind, an AI model designed to advance life sciences research, supporting tasks like drug discovery, biochemistry, and experimental planning. The system can analyze scientific data, generate hypotheses, and suggest experiments, aiming to accelerate early-stage breakthroughs, and is being tested with partners such as Moderna and Amgen.